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Sheep are not only a major livestock species globally, they are also an important
large animal model for biomedical research and have contributed to our understanding
of the ontogeny and architecture of the mammalian immune system. In this study,
we applied immunohistochemistry and multicolor immunofluorescence in fixed and
paraffin-embedded lymph nodes to phenotype the key populations of antigen presenting
cells, lymphocytes, and stromal cells that orchestrate the host adaptive immune
response. We used an extensive panel of antibodies directed against markers associated
with dendritic cells (MHC class II, CD83, and CD208), macrophages (CD11b, CD163,
and CD169), stromal cells (CNA.42, S100, and CD83), and lymphocytes (CD3, Pax5,
CD4, CD8). Using different methods of tissue fixation and antigen retrieval, we provide
a detailed immunophenotyping of sheep lymph nodes including the identification of
potential subpopulations of antigen presenting cells and stromal cells. By characterizing
cells expressing combinations of these markers in the context of their morphology and
location within the lymph node architecture, we provide valuable new tools to investigate
the structure, activation, and regulation of the sheep immune system in health and
disease.
Keywords: sheep, lymph node, antibody, immunohistochemistry, confocal microscopy, dendritic cell, stromal cell,
macrophages
INTRODUCTION
For more than 10,000 years domestic ruminants have played an important role in most human
societies as a source of meat, milk, and dairy products, textile, and labor. In developing countries,
cattle, sheep, and goats remain one of the main sources of livelihoods for millions of poor
smallholder farmers (1, 2). In more industrialized countries, the livestock sector is increasingly
organized in long marketing supply chains that employ at least 1.3 billion people globally and
accounts for 53% of agricultural GDP (2). For these reasons, diseases affecting animal health can
have a profound impact on the global economy. The majority of the currently emerging human
pathogens are of animal origin. Small ruminants can transmit a variety of diseases to humans
such as brucellosis, leptospirosis, listeriosis, Q Fever, chlamydophilosis, and tuberculosis (3) and
act as reservoirs for emerging arboviral infections that impact on human health such as Rift Valley
Fever (mosquito-borne) and Crimean Congo haemorrhagic fever (tick borne). These diseases all
involve complex host-pathogen interactions that need to be dissected for the development of safe
and effective control strategies, including novel vaccines.
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Due to its size and accessibility, the sheep has been used
as a suitable biomedical model to understand fundamental
immunological mechanisms. For example, in utero thymectomy
in fetal lamb revealed the ontogeny of T cell development (4)
while lymphatic cannulation in adult sheep has been essential to
our understanding of lymphoid and myeloid cell recirculation
and compartmentalization (5). These studies advanced our
capability to conduct basic ovine immunology, most notably
through the production of cell-subset specific monoclonal
antibodies (6). While there have been many improvements, the
tools to study the sheep immune responses remain relatively
limited in relation to those available for mice (7–12).
Therefore, while mice remain the biomedical model of choice
for studying a variety of human and animal diseases, it is
unrealistic to expect genetically manipulated “custom-made”
mouse strains to be representative of every aspect of the
intricate interplay between a pathogen and his host. Pathogen-
host interactions are influenced by their co-evolutionary history.
Hence, observations made in mouse models of disease do not
necessarily recapitulate the interactions between pathogens and
their natural host (13, 14). Large animals like sheep can provide a
unique opportunity to study naturally occurring diseases in their
target species both in the field and in experimental conditions;
hence the community need for improved immunological
tools.
Imaging techniques such as immunohistochemistry and
immunofluorescence allows the identification of cellular markers
in the context of their anatomical location. These techniques
provide unique information on cellular interactions within the
architecture of the tissues and are synergistic to flow cytometry
which is instead a more robust method to provide quantitative
data on a large number of cells. As part of a previously published
study (15), we described sheep lymph nodes (LNs) infected by
bluetongue virus to define the cellular changes that adversely
affect the development of host immune responses. LNs are
crucial lymphoid organs for antigen presentation, and for the
subsequent development of an adaptive immune response able
to counteract infections. Therefore, we have evaluated more than
fifty monoclonal and polyclonal antibodies, in order to identify
markers able to recognize distinct cell types in fixed and paraffin-
embedded sheep LNs. Our study will facilitate further research
needing to define the anatomy and compartmentalization of the
ovine peripheral LNs in basic and applied immunological studies
in sheep.
MATERIALS AND METHODS
Animals
Sheep LNs were sourced at the Istituto Zooprofilattico
Sperimentale dell’Abruzzo e del Molise “G. Caporale” (Teramo,
Italy) in accordance with locally and nationally approved
protocols regulating animal experimental use (protocol
numbers 7440; 11427; 12301). Skin-draining LNs (prescapular,
retromandibular, inguinal, and popliteal) were collected from 10
healthy sheep (Sardinian or mixed breed) during post-mortem
examination.
Preparation of Tissues
Tissue samples were cut sagittally and placed into processing
cassettes. The cassettes were immersed in either a 10% neutral
buffered formalin solution (Sigma, United Kingdom) or a
1% zinc salts fixative solution (at a ration 10: 1 solution
volume/sample volume; BD Pharmingen) and allowed to sit
for 24–48 h at room temperature before processing. After 48 h,
tissues were removed from the fixative solutions, dehydrated in
increasing concentration of ethanol (from 0 to 100%), cleared in
xylene and embedded in paraffin blocks as per standard histology
protocols.
Preparation of Sections for Labeling
Tissue sections were cut with a microtome (4µm thickness)
and mounted on microscope slides. Sections were deparaffinised
with multiple passages in xylene, re-hydrated in decreasing
concentration of ethanol and then rinsed in water.
Antigen Retrieval
Different types of antigen retrieval techniques were tested on
formalin-fixed, paraffin embedded tissues to unmask specific
epitopes. For heat-induced epitope retrieval (HIER), sections
were treated with Access Retrieval Unit (Menarini) in sodium
citrate buffer (pH 6), for 1min 30 s at 125◦C at full pressure,
then rinsed in Tris buffer pH 7.5. For protease induced epitope
retrieval (PIER), proteolytic digestion of formalin-fixed tissues
was performed using either a ready-to-use solution of proteinase-
K in 0.05M Tris-HCl, 0.015M sodium azide, pH 7.5 (Dako,
United Kingdom) for 10min at 37◦C, or a trypsin solution (0.05%
trypsin, 1% CaCl2, and 0.05% chymotrypsin) pH 7.8 (Sigma,
United Kingdom) for 20min at 37◦C and then rinsed with PBS.
Immunohistochemistry (IHC)
After antigen retrieval, the tissue sections were permeabilised
with a PBS solution of 1% Triton-X (Sigma) for 10min at
room temperature (RT). Slides were then treated for 30min at
RT with 3% hydrogen peroxide in PBS to quench endogenous
peroxidase activity. After washing 3 times with PBS 0.05% Tween
20 (PBS-T20), the sections were incubated for 80min with a
blocking buffer containing 5% bovine serum albumin in PBS
to block unspecific binding sites. Primary antibodies specific
or cross-reactive to sheep antigens (Table 1) were diluted in
blocking buffer and incubated with the tissue sections overnight
at 4◦C. Excess of primary antibodies was removed by washing
with PBS-T20. For primary antibody detection, sections were
incubated with appropriate isotype specific secondary antibodies
conjugated with horseradish peroxidase (HRP) for 1 h at RT. This
was followed by a 5min incubation with 3,3′-diaminobenzidine
(DAB) substrate-chromogen (EnVision+ System, Dako). Tissues
were counterstained using Mayer’s haematoxylin and mounted
with clear resin and coverslips for long-term storage. Tissue
sections were screened using a bright fieldmicroscope (Olympus)
and images captured using cell∧D software (Olympus).
Immunofluorescence
Tissue sections were treated as previously described for IHC
with the following modifications. After primary antibody
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TABLE 1 | List of antibodies successfully used in this study.
Specificity Ab Clone Host/Targeta Isotypeb Sourcec Resultsd Known cross reactivity in
sheep (References)‡
AA identity with sheep
orthologue (%)
Original
References
CD3† F7.2.38 Mo α Hu IgG1 Dako F Tested in ruminants (16, 17) 92* (18)
WC1 CC15 Mo α Bv IgG2a Bio-Rad F Yes (8) – (19)
CD8 CC63 Mo α Bv IgG2a Bio-Rad Z Yes (8) – (20)
CD8 38.65 Mo α Sh IgG2a Bio-Rad Z – – (21)
CD4 44.38 Mo α Sh IgG2a Bio-Rad Z – – (21)
CD21 (CR2) CC21 Mo α Bv IgG1 Bio-Rad Z Yes (22) – (23)
Pax5 (BSAP)† Dak-Pax5 Mo α Hu IgG1 Dako F – 97 (24)
MHC-II SW73.2 Rat α Sh MRI F – – (25)
CD11b CC126 Mo α Bv IgG2b Bio-Rad Z Yes (26) – (27)
CD163 EDHu-1 Mo α Hu IgG1 Bio-Rad F Yes (28) 82 (29)
CD68 EBM11 Mo α Hu IgG1 Dako I Yes (30) – (31)
CD169 (Siglec-1)† HSn 7D2 Mo α Hu IgG1 Santa
Cruz
Biotech
Z – 76 (32)
Fascin† 55K-2 Mo α Hu IgG1 Dako F – 93 (33)
CD83† HB15e Mo α Hu IgG1 Bio-Rad F – 73 (34)
CD208 (DC-LAMP) 1010E1.01 Rat α Mo IgG2a Dendritics F Yes (35) – (36)
CD45 1.11.32 Mo α Sh IgG1 Bio-Rad Z – – (37)
FDC† CNA.42 Mo α Hu IgM Dako F Tested in cattle (38) – (39)
CD54 (ICAM-1) † 117G12 Mo α Hu IgG1 Dendritics Z Stated by the vendor 56 (40)
CD321 (JAM-A) † Rb α Hu PL Invitrogen Z – 75
S100† Rb α Bv PL Dako F – 100
Desmin DE-U-10 Mo α Hu IgG1 Sigma-
Aldrich
F Yes (41) – (42)
Desmin† Rb α Mo PL Abcam F – 97
Beta-actin† 13E5 Rb α Hu IgG Cell
Signaling
F – 100
Smooth muscle actin 1A4 Mo α Hu IgG2a Dako F Yes (43) – (44)
Podoplanin (gp38) † D2-40 Mo α Hu IgG1k Dako I – 50 (45)
Von Willebrand Factor† Rb α Hu PL Dako F – 82 (46)
Vimentin Vim3B4 Mo α Hu IgG2ak Dako F Yes (43) – (47)
Perlecan† A71 Mo α Bv IgG1 Source
Bioscience
F – 97 (48)
PLVAP† MECA-32 Rt α Mo IgG2a Bio-Rad F – 74 (49)
Ki-67 MIB-1 Mo α Hu IgG1 Dako F (50) – (51)
†Antibody newly tested in sheep in this study.
aMo, mouse; Hu, human; Rb, rabbit; Sh, sheep; Bv, cattle; Gt, goat.
bPL, polyclonal.
cMRI, Moredun Research Institute–Penicuik.
dF, signal in formalin-fixed tissues; Z, signal in zinc salts fixed tissue; I, inconsistent results.
‡Numbers refer to reference/s describing sheep cross-reactivity.
*Cytoplasmic region of the CD3ε chain.
incubation, sections were rinsed in PBS-T20, and incubated
with an appropriate combination of anti-mouse, rabbit or
rat species- or isotype-specific fluorescently labeled secondary
antibodies (AlexaFluor 488, 555, 594, 633; Thermo Fisher)
for 1 h at RT. Excess secondary antibodies was removed
by PBS-T20 washes and sections were mounted using a
liquid antifade mounting media (Prolong Gold, Thermo
Fisher) containing 4′,6-diamidino-2-phenylindole (DAPI) for
chromatin staining. The sections were stored at 4◦C and
analyzed within a week from preparation. Fluorescently labeled
samples were examined using a Zeiss LSM710 confocal
microscope. Images were captured and processed using Zeiss Zen
software.
Criteria Employed for the Screening of
Antibodies
We screened a panel of 54 antibodies to identify cell
subpopulations present in the sheep LN fixed in either formalin
or zinc salt solution. Each working antibody was tested in LNs
coming from a minimum of 3 different individuals to confirm
reactivity. We tested both antibodies that were described as
specific or cross-reactive with sheep antigens and others which
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were identified as specific for human/rodent cellular markers.
For antibodies where cross-reactivity with ruminant targets was
not stated by the manufacturers, we carried out a BLAST (basic
local alignment search tool) search of the sheep genome in order
to define the level of conservation of the epitope/s (or entire
proteins) between sheep and the species targeted by the antibody.
The reactivity of antibodies raised against proteins sharing at
least 50% identity with the sheep orthologous was then tested by
immunohistochemistry. Antibodies were tested initially in zinc
salts fixed tissues as antigen retrieval is not required with this type
of fixation (52).
To determine the presence of a positive signal we initially
used antibody dilutions between 1:20 and 1:200, with the final
working concentration chosen for each individual antibody
based on the results of the staining. The specificity of the
staining was evaluated using histological insights, primarily
confirmation that the localization of the staining in the tissue
matched the expected anatomical localization of the targeted
cells. However, in some cases, specific signals were obtained in
unexpected cell populations. In these cases the targeted cells
were further characterized by co-expression of specific markers
using a combination of two or three antibodies by confocal
microscopy. In general, we tended to use well-recognized
markers, or previously characterized ones, in association with
newly identified ones.
Testing of antibodies in formalin-fixed tissues additionally
included also the evaluation of different antigen retrieval
techniques for the unmasking of hidden epitopes due to protein
cross-linking. The combined use of multiple primary antibodies
in multicolour immunofluorescence studies was limited by their
reactivity using the same antigen retrieval technique and species
in which they were raised, or, in case of mouse antibodies, by
the isotype class. The species, isotype and concentration of the
antibodies being evaluated were matched with negative control
antibodies against unrelated targets to confirm specificity of
staining.
RESULTS
Using the in-situ imaging techniques described above, we
identified 30 antibodies capable of recognizing cell markers
in fixed sheep LNs (Table 1). These antibodies provided a
clear specific signal with no or minimal unspecific background
staining. Eleven of the 30 antibodies solely worked on tissues
fixed in zinc salts without requirement for further antigen
retrieval (Table 1).
Lymphocyte Markers
To detect T lymphocytes we usedmAb F7.2.38 (Table 1) targeting
the intracytoplasmic portion of the ε-chain of human CD3, which
is highly conserved in mammals (18), and presented 92% identity
with the sheep orthologue protein. This mouse mAb has been
successfully used to identify CD3+ T cells in fixed tissue of
other ruminant species closely related to sheep (16, 17). In ovine
tissues, mAb F7.2.38 identifies cells that occupy the paracortical
area of the LN (Figures 1A,B). As expected, some positive cells
were also present along the medullary cords but not inside
the medullary sinuses, nor in the subcapsular sinus or inside
the trabecular sinuses. We observed lymphocyte subpopulations
in similar localizations as previously described (52). For the
identification of CD8+ T cells, we obtained overlapping results
by using in zinc fixed tissue an anti-bovine mAb (CC63) cross-
reactive with sheep and an anti-sheep mAb (clone 38.65 –
Figure 1A): CD8+ T lymphocytes were evenly distributed in the
cortical area but absent from the medulla as previously shown
(52). We stained WC1+ T lymphocytes by using a sheep cross-
reactive mAb (CC15), which identified γδ T cells localized in the
interfollicular area and along the cortical and medullary sinuses
(Figure 1A). For CD4T cells, we used an anti-sheep mAb (44.38)
that was previously reported to work in zinc salt fixed tissues
(53), allowing the identification of CD4+ lymphocytes that were
mainly confined to the follicles, where they provide help to B cells,
and in lower number scattered in the paracortex (Figure 1C).
We also tested antibodies directed against three different
markers commonly used for the identification of B lymphocytes:
CD79a, CD21, and Pax5 (Figures 1C,D). The anti-humanCD79a
(clone HM57) gave inconsistent staining and therefore was not
considered a reliable detector for B lymphocytes in fixed and
paraffin-embedded sheep LNs (data not shown). We then used
a validated cross-reactive anti-bovine mAb CC21to stain the
ovine CD21 (complement receptor 2, CR2) (22, 23, 54). CD21
is expressed on the membrane of both mature B cells and FDC
in sheep lymphoid tissues (52, 55–57) and, in agreement with
previous description, it was mainly present in the lymphoid
follicles (Figure 1C). The mAb Dak-pax5 (24) targets the Pax5
protein (B cell specific activator protein; BSAP), which is
expressed in the nucleus of B cells in all the maturation stages,
but not in plasma cells (58). Pax5 plays an essential role in B
cell commitment as it is involved in the repression of non-B
lymphoid genes and the activation of genes needed for B cell
differentiation (24, 58). Similarly to CD21, anti-Pax5 antibody
identified B cells in the follicles of the LN but not FDC, hence
we consider it a more specific marker for B cells by IHC and IF
(Figure 1C). B cells express MHC Class II (MHC II) on their
surface and we could confirm co-expression with Pax5 in the
follicular area (Figure 1D). Potential antibodies against other
pan-B cell markers used to identify B cells in other species such
as CD19 for human or CD45R/B220 in mouse are not currently
available for ruminant species.
Markers for Mononuclear Phagocytes
A broad variety of markers have been used to characterize
different populations of antigen presenting cells in the mouse
and humans (59, 60) but there are limited data regarding
subpopulations of mononuclear phagocytes in sheep LN. Hence,
we tested systematically a panel of antibodies to identify dendritic
cells and macrophages in sheep LNs.
We firstly analyzed markers putatively specific for
macrophages. Different subpopulations of macrophages are
generally present in the LN, where they are mainly localized
along the trabecular and medullary sinuses to capture and
present antigen flowing through the lymphatic system (60).
CD11b (also known as MAC-1 or CR3) has been frequently
associated with macrophages in sheep (61, 62). As expected,
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FIGURE 1 | Identification of sheep lymphocytes by immunohistochemistry and immunofluorescence. Representative immunohistochemistry and confocal
micrographs of sheep lymph node sections derived from paraffin-embedded tissues fixed in zinc salt solution. (A) Immunohistochemistry: sections were stained for
CD3, CD8 (clone 38.6), or WC1 to identify T lymphocytes, cytotoxic T cells, and gamma-delta T cells, respectively. Scale bar: 100µm for cortex and 50µm for
paracortex and medulla. (B) Confocal microscopy of sections stained for CD3 and smooth muscle actin (SMA, white). (C) Immunohistochemistry of sections stained
for CD4 to identify T helper cells. Scale bar: 50µm. (D) Immunohistochemistry of sequential sections stained for CD21 and PAX-5 (BSAS protein), both markers to
identify sheep B lymphocytes. Scale bar: 250µm for cortex and 50µm for follicle inset. (E). Confocal microscopy of sections stained for PAX-5 (red) and MHCII
(green) expressed by B lymphocytes, a rim of SMA (white) delimits the follicle. Scale bar: 100µm.
CD11b was expressed by a few cells localized along the trabecular
and medullary sinuses but was not detected in the T cell area
of the cortex (Figure 2). This observation is in agreement with
previous studies reporting small numbers of cells expressing
CD11b in the LN (26). CD163 is a glycoprotein belonging to
the scavenger receptor cysteine-rich superfamily that in human
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FIGURE 2 | Identification of markers for sheep macrophages and dendritic cells. Representative immunohistochemistry micrographs of sheep lymph node sections
fixed using zinc salt solution. Sequential tissue sections stained for CD11b, CD163, CD169, CD208, and fascin. Insets show the paracortical area at higher
magnification. The expression of these markers in different anatomical areas of the lymph node allowed the identification of various populations of mononuclear
phagocytes. Scale bar: 100µm for cortex and 20µm for paracortex and medulla.
is mostly expressed on tissue-resident macrophages (63) and in
sheep is considered to be exclusively expressed by monocytes
and macrophages and not expressed by neutrophils (unlike
CD68 for example) (28, 64). To identify CD163 expression, we
used the anti-human CD163 mAb (clone EDHu-1) previously
validated in ovine tissues (28). CD163 was expressed by a few
cells in the paracortical area and by numerous cells present along
the trabecular and medullary sinuses (Figure 2), in a similar
localisation as CD11b+ macrophages. The sialoadhesin CD169
(Siglec-1) is a lectin with Ig superfamily domains binding sialic
acid and in the mouse lymph node is expressed by macrophages.
In mouse LNs, CD169 characterizes two different types of
macrophages: SCS and medullary (65). These macrophages are
strategically placed along the sinuses where they are involved
in antigen acquisition and their delivery to lymphocytes. Here
we used the anti-human CD169 antibody clone HSn 72D, that
in zinc salt fixed tissues labeled a population of macrophages
present along trabecular and medullary sinuses but not in the
SCS. This pattern of expression starkly contrast with what has
been described in the mouse (Figure 2) (66).
We then screened antibodies targeting markers normally
expressed by dendritic cells. Dendritic cells can be found in
the paracortical area of the LN, where they interact with T
cells for antigen presentation and activation. In humans, CD208
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(Dendritic cell-lysosomal associated membrane protein, DC-
LAMP) is specifically expressed by DCs upon activation (67).
The anti-human CD208 antibody (clone 1010E1.01) is cross-
reactive with sheep (35) and has been previously used to identify
bovine dendritic cells in formalin-fixed tissues (38). In sheep LN,
CD208 appeared to be expressed by two distinct cell populations
residing in the paracortical area: the first population expressed
CD208 abundantly in the cytoplasm, while the second population
showed CD208 clustered in a limited perinuclear area (Figure 2);
this latter pattern of expression was also detected in cells,
likely macrophages, present along trabecular, and medullary
sinuses.
Fascin has been demonstrated to be critical for antigen
presentation by mature mouse and human DCs (68, 69). Indeed,
fascin is considered a specific marker for mature DCs and not
macrophages (70). Given the close relatedness of the human
and sheep protein (93% of AA identity, Table 1), we tested
the anti-human fascin mAb (clone 55-K2) in sheep LNs. As
expected, the anti-fascin antibody showed a strong labeling
of cells present in the paracortical area, where DC reside,
highlighting the membrane processes extending outward the
cell body (Figure 2). In the paracortical and medullary sinuses,
fascin was also detectable in macrophages at very low levels
(Figure 2).
CD83 is broadly used as a maturation marker for human and
mouse DCs (71), nevertheless it is also expressed on a variety
of different cells, including monocytes, and macrophages (72),
activated B and T lymphocytes (73–75) and some epithelial cell
populations. CD83 expression in sheep has been described in
pseudo-afferent lymph DCs (76). To test its expression in LNs,
we used the anti-human CD83 mAb (HB15e). HB15e identified
dendritic cells present in the paracortical area displaying a
marked cytoplasmic localization, while it was not detected in
macrophages located along the sinuses. In addition, the anti-
human CD83 antibody labeled cells present in the B cell
follicles forming a fine reticulum (Figure 3A), a staining pattern
consistent with that expected for FDC.
To further characterize the phenotype of sheep DCs and
macrophages, we combined relevant markers using multicolour
confocal microscopy (Figures 3, 4). In particular, we combined
newly tested antibodies with a previously validated anti-sheep
MHC II to further confirm their co-expression in antigen
presenting cells (Figure 3). The mAb SW73.2 (25) recognizes
a monomorphic epitope on both DQ and DR beta chain
of sheep and cattle MHC II constitutively expressed on
antigen presenting cells such as dendritic cells, B lymphocytes,
monocytes, and macrophages. In fixed LN, MHC II was
expressed at high levels by interdigitating cells present in
the paracortex (Figure 3) and at a lower level by the B
lymphocytes present in the follicles (Figure 1E). In the medullary
sinuses, macrophages expressed MHC II at lower levels
(Figure 3).
CD83 was abundantly co-expressed with MHC II by cells in
the paracortical area that were morphologically consistent with
DCs and characterized by branched projections (Figure 3A),
while the same markers were expressed at low level in the
medullary macrophages. In the cortex, follicular B cells did not
express CD83, in contrast to what described in human andmouse
(74, 77).
High levels of fascin were also expressed in the dendrites
of MHC IIhigh cells of the paracortical area (Figure 3B). These
MHC IIhigh cells were negative for CD163 (Figure 3C). The
CD163+ cells present in the cortex presented low levels of MHC
II and in the medulla they appeared to be negative for MHC II
(Figure 3C).
Double staining for CD163 and CD208 revealed that high
expression of CD163 (a macrophage marker) and CD208 (a
DC marker) appeared to be mutually exclusive in sheep LN
(Figure 4A), with the exception of the follicles where both
markers seems to label tingible body macrophages (Figure 4A).
By using CD163 and CD208 in combination in the
paracortical area of the LN, we could identify three main
different antigen presenting cell populations: CD208+CD163−,
CD163+CD208−, and CD163+CD208low (Figure 4B), which
may represent different activation stages of the same cell type or
distinct cell populations possessing different functions. CD208+
cells also stained strongly positively for fascin (Figure 4C)
and for CD83 (Figure 4D) conveying a phenotype suggestive
of DC. In some cases, we observed that a small population
of CD208+CD83+ cells was positively labeled by the anti-
human CNA.42 mAb, as described for human DC (39),
which highlighted the long dendrites belonging to these cells
(Figures 4E,F).
In the medulla of the LN, the double staining for CD163
and CD208 allowed the detection of a population of cells
with the CD163+CD208low phenotype (Figure 4G). Staining of
these CD208low cells with the anti-fascin antibody revealed low
expression levels and no presence of dendrites (Figure 4H),
providing indication that these cells likely belong to the
monocyte-macrophage compartment. Along the medullary
sinuses, we could identify CD169+ cells by confocal microscopy,
in a similar position as CD163+ macrophages (Figure 4I).
Stromal Cells Markers
In recent years, stromal cells have been recognized as having
a key role in facilitating the antigen presentation process (78,
79). Stromal cells provide the supporting network of fibers that
form the LN structure and produce activation cytokines (such
as IL-6, IL-7, IL-15, and BAFF) and homing signals (CXCL13,
CCL19, CCL21) to drive leucocytesmigration. Lymphoid stromal
cells are a heterogeneous population comprising groups of
highly specialized cells in different areas of the LN with defined
functions and phenotype (79). These distinct phenotypic and
functional characteristics of stromal cells have been described in
detail only in the mouse LN but not in other animal species.
Here, we aimed to characterize different populations of lymphoid
stromal cells of the sheep LN, and tried to identify markers
that unequivocally identify them by confocal microscopy in fixed
tissues.
Currently, two major subtypes of follicular dendritic cells
(FDC) have been identified in the germinal centers of mice
on the bases of their localization, morphology, phenotype, and
function. FDCs localized in the light zone display abundant
cytoplasmic extensions with a high level of membrane-bound
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FIGURE 3 | Differential expression of MHC II in dendritic cells and macrophages. Representative confocal micrographs of sheep lymph node sections. (A) Sections
stained for MHC II (green) and CD83 (red). (B) Sections stained for MHC II (green) and fascin (red) to visualize the extension of DCs in the paracortical area. (C)
Sections stained for MHC II (green) and CD163 (red). Markers expression in different areas of the lymph node is shown at higher magnification, DAPI (blue).
immune complexes, whereas in the dark zone they display
fewer cytoplasmic extensions and present a low capacity to trap
immune complexes (80).
We found sheep FDCs to react positively with the anti-
human CNA.42 antibody (15) (Figure 5) as already described for
cattle (38). The epitope recognized by CNA.42 is a membrane-
associated 120 kD antigen resistant to fixation that is expressed
on FDCs. CNA.42 is commonly used in human diagnostic
settings for the histological classification of malignancies of FDCs
origin (such as follicular dendritic reticulum cell sarcoma and
EBV-positive inflammatory pseudotumors) (39, 81, 82). In the
sheep LNs under study, this antigen was also expressed by some
mononuclear cells present in the paracortical area of the LN
as described for human LNs (39). We identified sheep FDC
as cells forming a reticular pattern in the light zone of the
germinal centers. Furthermore, FDC in the light zone were
positively labeled with an anti-human antibody targeting CD54
reported to work in sheep (Figure 5A). CD54 (also known as
intercellular adhesion molecule 1–ICAM-1) is a transmembrane
protein expressed by the endothelial cells and leukocytes which is
implicated in the process of transmigration of leucocytes across
lymphatic vessels (83). Both mouse and human FDCs have been
already shown to express CD54 (84, 85). CNA.42 and CD54 were
expressed in the same cell population in the follicles of the sheep
LNs (Figure 5A).
We also detected a second population of FDC localized
in the dark zone of the sheep germinal centers. These cells,
have been previously described in the literature as “dark
zone FDC” (dzFDC) or “dark zone reticular cells” but their
function has yet to be defined (80, 86, 87). DzFDC lacked
expression of the classical FDC marker CNA.42, but stained
positively for CD83 and S100 (Figure 5). CD83 was also
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FIGURE 4 | Identification of markers for sheep antigen presenting cells. Representative confocal images of sheep lymph node sections. (A) Sections stained for
CD163 (red) and CD208 (green) identify different populations of sheep phagocytes. In the follicle, colocalization (yellow) identifies tingible body macrophages. Inset:
single color at higher magnification. (B) Sections stained for CD163 (red) and CD208 (green) in the paracortical area of the lymph node (LN) identify different
cell-subsets. (C) Sections stained for fascin (red) and CD208 (green), both expressed at high levels in cells residing in the paracortical area. (D) Sections stained for
CD208 (green) and CD83 (red). Both markers are expressed in dendritic cells residing in the paracortex. (E) Sections stained for CD83 (green) and CNA.42 (red)
showing a population of CD83+CAN.42+ dendritic cells in the paracortical area, smooth muscle actin (SMA, white) highlights the capsule of the LN. Inset: higher
magnification. (F) Section stained for CD208 (white), CD83 (green), CNA.42 (red) to identify CD208+CD83+CNA.42+ dendritic cells. (G) Sections stained for CD163
(red) and CD208 (green), CD163 is mainly expressed in macrophages along the medullary sinuses. (H) Sections stained for fascin (red) and CD208 (green),
macrophages in the medullary sinuses express low levels of the two markers. (I) Sections stained for smooth muscle actin (SMA, white), JAM-A (green) and CD169
(red). CD169+ macrophages are present along the trabecules but not in the subcapsular area.
expressed on FDC in the light zone but at lower levels.
Markers for FDC (such as CNA.42) and dark zone reticular
cells (S100 and CD83) were co-expressed in the transition
area between the two regions (Figure 5) suggesting that
the dzFDC are a less specialized subpopulation of reticular
cells that might share a similar origin with the light zone
FDC.
Stromal cells populating the paracortical and medullar area,
but absent from the follicles are called fibroblastic reticular
cells (FRC). We identified FRC in the sheep LN as desmin
expressing cells, as previously reported for the mouse (88,
89) (Figure 6). In contrast to what observed in the mouse,
we could not detect smooth muscle actin (SMA) in sheep
FRC (88) but only in the LN capsule and in the pericytes
surrounding high endothelial venules (HEV). Interestingly, SMA
was also present on an arc-shaped line of cells delimiting the
paracortical border of each follicle and separating it from the
paracortex (Figure 6). We could not determine if these cells
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FIGURE 5 | Immunophenotyping of sheep follicular dendritic cells. Representative confocal micrographs of sheep lymph node sections. (A) Sections were stained for
CD83 (red) and CNA.42 (green). CD83 identified dark zone reticular cells present in the follicle. CNA.42 was expressed only by FDC in the light zone of the follicle. The
use of CD83 and CNA.42 allow identifying a dark (DZ) and a light zone (LZ) in the follicles. Note the expression of both markers in cells present at the border between
dark and light zone. (B) Sections stained for CD54 (red) and CNA.42 (green). CD54 and CNA.42 are both markers for light zone FDC. (C) Sections stained for S100
(red) and CNA.42 (green), S100 labels FDC in the dark zone. Nuclei are stained in blue (DAPI).
FIGURE 6 | Identification of sheep fibroblastic reticular cells (FRC) and marginal reticular cells (MRC). Representative confocal micrographs of sheep lymph node
sections. Sections were stained for desmin (rabbit polyclonal, red), CD83 (green), and SMA (white) to identify desmin+CD83− FRC in the paracortex, desmin−CD83+
MRC between follicle and subcapsular sinus, and desmin−CD83+ dark zone FDC in the follicle. SMA identifies the capsule of the LN.
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represent pericytes delineating a sinus surrounding each B cell
follicle.
Furthermore, just underneath the subcapsular sinus, in
correspondence with the follicles, we identified an additional
population of stromal cells expressing both desmin and
CD83 (Figure 6); these double positive cells (desmin+CD83+)
branched from the floor of the subcapsular sinus, in continuity
with sinus lining cells, toward the border of the follicles where
they reached the FDCs. Due to the anatomical localization of
these cells, and their expression of both FDC and FRC markers,
we identified them as marginal reticular cells (MRC). These cells
were recently described in the mouse LNs (90, 91) and appear to
be implicated in antigen delivery to the B cells.
Endothelial Cells Markers
Endothelial cells are also stromal cells and are an integral part
of the LNs considering that both blood and lymphatic capillaries
are critical to the anatomy and structure of this organ. We could
identify blood endothelial cells (BEC) by using an anti-human
Von Willebrand factor (VWF) polyclonal Ab (Figure 7A). BEC
could be differentiated from lymphatic endothelial cells (LEC),
which instead were localized along the SCS and expressed high
levels of CD83 but low level of VWF (Figure 7A). Plasmalemma
vesicle associated protein (PLVAP, a type 2 transmembrane
glycoprotein that is expressed in endothelium, Figure 7B) and
junction adhesion molecule-A (JAM-A, a tight-junction protein
present on endothelial, and epithelial cells) were also present on
the endothelial cells lining the sinus wall. In particular, PLVAP
staining appeared as a delicate capillary network that from the
SCS deepened in the underlying follicles, likely identifying the
initial part of the conduit system (92) (Figure 7B). To further
characterize the vessels in the LNs, we used an anti-bovine
perlecan, also known as heparan sulfate proteoglycan 2 (HSPG2),
a component of the basal membrane: this stain was able to
delineate the structure of small vessels and SCS (Figure 8). The
staining patterns of all of the cell populations described here are
summarized in Table 2.
DISCUSSION
Fundamental studies on immune responses in veterinary species
remain hampered by a relative lack of immunological reagents.
This can be rectified by the targeted production of new
antibodies, molecular probes, and technologies that address
specific gaps in capability for any given host species. Studies in
sheep have made major contributions to our basic understanding
of the ontogeny and organization of the mammalian immune
system. However, in recent years investment in the development
of ovine-specific immunological reagents has lagged behind most
other livestock species, creating a barrier to the advancement of
vaccine delivery, and disease pathogenesis studies. In this study,
more than 50 antibodies, originally developed for cell markers of
either ruminants or other species, were systematically tested in
order to identify and localize different cell populations in fixed
and paraffin embedded sheep LNs. Using the methods described
in this study, we were able to successfully immunophenotype
cells in the peripheral lymph node of sheep with 30 antibodies,
extending the immunological toolbox for this animal species.
Importantly, we propose the existence of various populations
of specialized stromal cells in the sheep lymph node, including
FRC, MRC, dark zone reticular cells, and sinus lining cells. Most
of these cell types have been so far described only in the mouse
although they play key roles in antigen delivery and presentation
(78, 79).
We identified different subsets of antigen presenting cells
in the LN by using a combination of antibodies in multicolour
confocal microscopy. These data complement previous studies
on sheep that have mainly focused on the use of flow cytometry
for the characterization of DCs collected from afferent lymph
or differentiated from blood precursors (26, 61, 93–96). While
the classification of ovine DC into the putative conventional
DC subtypes (namely cDC1 and cDC2) and monocyte derived
DC (mo-DC) focused mainly on the pool of circulating
cells, relatively few studies characterized LN-resident DCs
in sheep in situ. Recent studies have used a transcriptomic
approach to close the existing gap between DC classification
in different animal species (96). Unfortunately, some of the
antibodies against markers that are generally used to classify
these cells (such as CD11c and CD172a) did not work in
fixed tissue in our hands, making it difficult to draw a direct
comparison with previously identified DC subtypes. However,
the differential expression of markers considered specific
for antigen presenting cells still allowed the identification
of potentially three different cell-subsets, residing in the
cortical area (the histological location for DCs), and with
morphological characteristics of DC. The first population,
CD208highFascinhighMHC-IIhighCD83+ cells that generally
displayed low levels of perinuclear CD163−/int, presented a
phenotype compatible with classical DCs, whose function is to
contribute to the activation of T lymphocytes in the paracortical
area of the LN (59). The second population was less numerous
and combined the expression of the classical DC markers and
of CNA.42 (CNA.42+CD208highMHC-IIhighCD83+). Finally,
a third population of CD163+CD208int/−MHC IIlow cells
was abundant in the paracortex and presented a phenotype
compatible with macrophages or mo-DC due to the expression
of CD163, which is considered a monocyte/macrophage marker.
Macrophages, which colonize different areas of the LN, such
as the trabecular and medullary sinuses, were characterized by a
lower expression of the classical DC markers (such as MHC II,
fascin, and CD208) and a higher expression of CD163 or CD169.
In human, CD163 is considered a marker for M2 macrophages,
possessing mainly a homeostatic anti-inflammatory and tissue-
repair function that distinguish them from M1 macrophages
which present a pro-inflammatory phenotype (97). However,
markers for macrophages polarization have not yet been defined
in sheep. In some cases, CD163+ cells in the medullary cords
do not appear to express MHC II, it is possible that very low
levels of MHC II exceeded the limit of detection by confocal
microscopy, as the signal of antibody binding cannot be easily
amplified as with the standard HRP/AP IHC immunodetection
method. Interestingly, the lack of CD169 expression along the
sheep subscapular sinus, differ from what has been previously
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FIGURE 7 | Identification of markers for sheep endothelial cells. (A) Representative confocal microscopy micrographs of sheep lymph node (LN) sections showing the
expression of Von Willebrand Factor (VWF, green) in the cortical area of the LN. WVF expression identified cells lining high endothelial venules and subcapsular sinus.
Note co-expression with CD83. (B) Representative immunohistochemistry micrographs of sheep LN sections collected from uninfected control animals and fixed in
formalin. Sections were stained for plasmalemma vesicle associate protein (PLVAP) identifying thin cells lining the subcapsular sinus walls and branching inside the
follicles underneath.
FIGURE 8 | Markers for basal membrane and pericytes. Representative confocal microscopy micrograph of sheep lymph node sections stained for desmin (rabbit
polyclonal, red), perlecan (green) and SMA (white) to reveal the three-layered organization of the subcapsular sinus and of the high endothelial venules in the cortical
area of the lymph node.
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TABLE 2 | List of cell populations identified in this study in the sheep lymph node.
Cell type Markersa Localizationb Identified cells
Lymphocytes CD3 Paracortex T cells
CD8
CD3
Mainly in the
paracortex and
medullary cords
Cytotoxic T cells
WC1
CD3
Mainly in the
paracortex and
medullary cords
γδ T cells
CD4
CD3
Follicles and
paracortex
T helper and T
regulatory cells
CD79*
Pax-5
MHC II
Follicles B cells
CD21
Pax-5
MHC II
Follicles Follicular B cells
Antigen
presenting
cells
MHC II Expressed at
different levels in
various areas of
the LN
Dendritic cells,
Macrophages, B
cells, endothelial
cells
CD208
MHC IIhigh
Fascinhigh
CD83
CD163low/−
Paracortex Dendritic cells
CNA.42
CD208
MHC IIhigh
Fascinhigh CD83
Paracortex Dendritic cells
CD163
MHC IIlow/−
CD208int/−
CD169−
Paracortex, few
inside the SCS
Macrophages
CD169
CD163
MHC-II
Fascinlow
Along trabecular
and medullary
Sinuses
Macrophages
CD208
CD163
Follicle (2–4 per
follicle)
Tingible body
macrophages
Stromal cells Desmin
SMA
Capsule Capsule
SMA Trabecules and
around vessels
Trabecules and
perycites
Desmin Paracortex FRC
Desmin
CD83
Between the SCS
and the follicle
MRC
CNA.42
CD21
CD54
CD83low/−
Light zone of the
follicle
FDC
CD83
S100
Dark zone of the
follicle
Dark zone reticular
cells
(Continued)
TABLE 2 | Continued
Cell type Markersa Localizationb Identified cells
VWFhigh Paracortex and
hilum
HEV and blood
vessels
CD83
PLVAP
VWFlow
Lining subcapsular
sinus, lining
trabecular sinuses,
enveloping sinus
traversing conduits
Sinus lining cells
aMHC II, Major Histocompatibility Complex Class II; SMA, smooth muscle actin; JAM-A,
junction adhesion molecule-A; VWF, Von Willebrand factor; PLVAP, plasmalemma vesicle
associated protein.
bFRC, Fibroblastic reticular cells; MRC, marginal reticular cells; FDC, follicular dendritic
cells; HEV, high endothelial venules.
*Inconsistent results.
described for mouse LN. Overall, none of the antigen presenting
cell markers used in this study allowed a clear identification
of subcapsular macrophages in sheep LN; whether this finding
reflects a lack of expression of these proteins in sheep SCS
macrophages or an evolutionary difference between the two
species will require further studies, possibly using RNA-probes
in situ. Attempts to separate SCS macrophages from the tissues
have been unsuccessful, and it is therefore difficult to describe the
phenotype of this elusive population in detail by flow cytometry
(98).
In the follicular area, apart from B cells, CD4+ lymphocytes,
and FDC, we proposed the identification of follicular
macrophages (also called tingible body macrophages), which
co-expressed CD208 and CD163. CD208 is generally considered
a specific marker for DC but in ruminants it has already been
reported in tingible body macrophages (38).
Many more cell subtypes have been identified in the
LN of the mouse and human, based on surface markers
expression, cytokine profile, embryological origin, migration
patterns, and antigen presentation capacity. Whenever possible,
we tried to make a direct comparison with sheep subsets,
but additional functional studies are required to achieve a
clearer characterization of the different cell types identified
in this study. In the future, the increased use of singe-
cell sequencing technologies (99) and robust RNA in situ
hybridization techniques will expand our ability to characterize
rare populations of cells in the LNs of large animals and allow
us to better appreciate the diversity characterizing each animal
species.
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